• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转化酶作为精神和神经退行性疾病的可用药靶。

Angiotensin-converting enzymes as druggable features of psychiatric and neurodegenerative disorders.

机构信息

Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.

Department of Psychiatry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.

出版信息

J Neurochem. 2023 Jul;166(2):138-155. doi: 10.1111/jnc.15806. Epub 2023 Mar 27.

DOI:10.1111/jnc.15806
PMID:36908214
Abstract

The renin-angiotensin system (RAS) plays essential roles in maintaining peripheral cardiovascular homeostasis, with its potential roles in the brain only being recognized more recently. Angiotensin-I-converting enzyme (ACE) is the main component of the RAS, and it has been implicated in various disorders of the brain. ACE and other RAS components, including the related enzyme ACE2, angiotensin peptides and their respective receptors, can participate in the pathological state, as well as with potential to contribute to neuroprotection and/or to complement existing treatments for psychiatric illness. In this narrative review, we aimed to identify the main studies describing the functions of the RAS and ACEs in the brain and their association with brain disorders. These include neurodegenerative disorders such as Parkinson's and Alzheimer's diseases, psychiatric illnesses such as schizophrenia, bipolar disorder, and depression. We also discuss the possible association of a functional polymorphism of the ACE gene with these brain diseases and the relevance of the neuroprotective and anti-inflammatory properties of ACE inhibitors (ACEis) and angiotensin receptor blockers (ARBs). Based on this, we conclude that there is significant potential value to the inclusion of ACEis and/or ARBs as a novel integrated approach for the treatment of various disorders of the brain, and particularly for psychiatric illness.

摘要

肾素-血管紧张素系统(RAS)在维持外周心血管稳态方面发挥着重要作用,其在大脑中的潜在作用最近才被认识到。血管紧张素转换酶(ACE)是 RAS 的主要组成部分,它与大脑的各种疾病有关。ACE 和其他 RAS 成分,包括相关酶 ACE2、血管紧张素肽及其各自的受体,都可以参与病理状态,并有可能有助于神经保护和/或补充现有的精神疾病治疗方法。在这篇叙述性综述中,我们旨在确定描述 RAS 和 ACE 在大脑中的功能及其与大脑疾病关联的主要研究。这些疾病包括神经退行性疾病,如帕金森病和阿尔茨海默病,以及精神疾病,如精神分裂症、双相情感障碍和抑郁症。我们还讨论了 ACE 基因的一种功能性多态性与这些脑部疾病的可能关联,以及 ACE 抑制剂(ACEIs)和血管紧张素受体阻滞剂(ARBs)的神经保护和抗炎特性的相关性。基于这些,我们得出结论,将 ACEIs 和/或 ARBs 作为一种治疗各种脑部疾病的新的综合方法,特别是治疗精神疾病,具有重要的潜在价值。

相似文献

1
Angiotensin-converting enzymes as druggable features of psychiatric and neurodegenerative disorders.血管紧张素转化酶作为精神和神经退行性疾病的可用药靶。
J Neurochem. 2023 Jul;166(2):138-155. doi: 10.1111/jnc.15806. Epub 2023 Mar 27.
2
Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients.血管紧张素转化酶 2 水平与心血管疾病患者应用肾素-血管紧张素抑制剂的相关性。
BMC Pharmacol Toxicol. 2023 Apr 14;24(1):24. doi: 10.1186/s40360-023-00667-w.
3
Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.针对大脑肾素-血管紧张素系统预防和治疗阿尔茨海默病:过去、现在和未来。
Ageing Res Rev. 2022 May;77:101612. doi: 10.1016/j.arr.2022.101612. Epub 2022 Mar 26.
4
Pharmacogenetics of angiotensin modulators according to -ϵ4 alleles and the insertion/deletion polymorphism in Alzheimer's disease.根据-ϵ4等位基因及阿尔茨海默病中的插入/缺失多态性研究血管紧张素调节剂的药物遗传学。
Acta Neuropsychiatr. 2023 Dec;35(6):346-361. doi: 10.1017/neu.2023.38. Epub 2023 Aug 22.
5
Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.肾素-血管紧张素系统与阿尔茨海默病的病理生理学:从潜在相互作用到治疗前景
Protein Pept Lett. 2020;27(6):484-511. doi: 10.2174/0929866527666191230103739.
6
Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical Trials.肾素血管紧张素阻滞剂与心脏保护:从基础到临床试验。
Am J Hypertens. 2022 Apr 2;35(4):293-302. doi: 10.1093/ajh/hpab108.
7
The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?脑肾素-血管紧张素系统在帕金森病神经病理学中的潜在作用:朋友、敌人还是叛徒?
J Cell Mol Med. 2024 Jun;28(12):e18495. doi: 10.1111/jcmm.18495.
8
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.肾素-血管紧张素系统抑制剂在慢性肾脏病患者的肾脏和心血管结局中的作用:一项随机临床试验的贝叶斯网络荟萃分析。
Am J Kidney Dis. 2016 May;67(5):728-41. doi: 10.1053/j.ajkd.2015.10.011. Epub 2015 Nov 18.
9
Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.脑内血管紧张素 II 和血管紧张素 IV 受体作为潜在的阿尔茨海默病治疗靶点。
Geroscience. 2020 Oct;42(5):1237-1256. doi: 10.1007/s11357-020-00231-y. Epub 2020 Jul 22.
10
Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19.肾素-血管紧张素系统通路治疗与 COVID-19 住院男性患者的改善结局相关。
Crit Care Med. 2022 Sep 1;50(9):1306-1317. doi: 10.1097/CCM.0000000000005589. Epub 2022 May 18.

引用本文的文献

1
Uncovering Proteins Commonly Expressed Between Heart Failure and Dementia Using Bioinformatic Tools.使用生物信息学工具揭示心力衰竭和痴呆症之间共同表达的蛋白质。
Curr Issues Mol Biol. 2025 Jun 9;47(6):437. doi: 10.3390/cimb47060437.
2
Comparative Risk Assessment in Hypertensive Patients With Metabolic Syndrome by Exploring Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.通过探索血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂对高血压合并代谢综合征患者进行比较风险评估
Cureus. 2025 Jun 8;17(6):e85564. doi: 10.7759/cureus.85564. eCollection 2025 Jun.
3
Telmisartan mitigates behavioral and cytokine level alterations but impairs spatial working memory in a phencyclidine-induced mouse model of schizophrenia.
在苯环利定诱导的小鼠精神分裂症模型中,替米沙坦可减轻行为和细胞因子水平的改变,但会损害空间工作记忆。
Psychopharmacology (Berl). 2025 May 23. doi: 10.1007/s00213-025-06805-y.
4
Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2.用于血管紧张素转换酶 2 的分子成像的放射性示踪剂。
Int J Mol Sci. 2024 Aug 30;25(17):9419. doi: 10.3390/ijms25179419.
5
Current understanding of the link between angiotensin-converting enzyme and pain perception.目前对血管紧张素转换酶与疼痛感知之间联系的认识。
Drug Discov Today. 2024 Sep;29(9):104089. doi: 10.1016/j.drudis.2024.104089. Epub 2024 Jul 6.
6
Total Synthesis and Bioactivity Profile of (+)-Ieodomycins A and B and their Stereoisomers.(+)-碘霉素A和B及其立体异构体的全合成与生物活性概况
ACS Omega. 2024 Jun 12;9(25):27592-27609. doi: 10.1021/acsomega.4c03241. eCollection 2024 Jun 25.
7
High-throughput single biomarker identification using droplet nanopore.使用液滴纳米孔进行高通量单一生物标志物识别
Chem Sci. 2024 Apr 10;15(22):8355-8362. doi: 10.1039/d3sc06795e. eCollection 2024 Jun 5.
8
Renin-angiotensin system inhibitor use and risk of Parkinson's disease: a meta-analysis.肾素-血管紧张素系统抑制剂的使用与帕金森病风险:一项荟萃分析。
Acta Neurol Belg. 2025 Feb;125(1):53-60. doi: 10.1007/s13760-024-02560-7. Epub 2024 Apr 26.
9
Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression.狼疮自身抗体引发的神经炎症由持续的 HMGB1:RAGE 信号维持,并通过增加 LAIR-1 表达得到逆转。
Nat Immunol. 2024 Apr;25(4):671-681. doi: 10.1038/s41590-024-01772-6. Epub 2024 Mar 6.
10
The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury.肾素血管紧张素系统在创伤性脑损伤中的治疗靶点作用
Neurotherapeutics. 2023 Oct;20(6):1565-1591. doi: 10.1007/s13311-023-01435-8. Epub 2023 Sep 27.